Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2003
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166289 Compositions and methods for regulating bacterial pathogenesis
09/04/2003US20030166288 Altering Ku80 levels in plants; recobinant expression cassettes
09/04/2003US20030166279 Minicell-based transfection
09/04/2003US20030166258 Saccharomyces cerevisiae yeast strain with functional expression of a glut transporter
09/04/2003US20030166257 Use of Lactobacillus salivarius
09/04/2003US20030166255 Culturing a host cell for expressing a first recombinant protein isoprenoid synthase and a second recombinant protein cytochromes, for transforming a disease resistance plants; genetic engineering
09/04/2003US20030166251 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor
09/04/2003US20030166249 PEG-urate oxidase conjugates and use thereof
09/04/2003US20030166248 Proteases from gram-positive organisms
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166235 Enzyme inhibitors; immunoassay
09/04/2003US20030166234 A METHOD FOR PREPARING MASSIVELY RmlC PROTEIN AND PURIFIED RmlC PROTEIN OF MYCOBACTERIUM TUBERCULOSIS BY IT
09/04/2003US20030166232 PARG, a GTPase activating protein which interacts with PTPL1
09/04/2003US20030166228 Anti-interferon-alpha antibodies
09/04/2003US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166212 Alpha1,3-fucosyltransferase
09/04/2003US20030166211 Alpha-1,3 fucosyltransferases and expression systems for making and expressing them
09/04/2003US20030166207 Nucleic acid and amino acid sequences for acetolactate synthase, acetolactate synthase regulatory regions, alpha-tubulin promoter, a promoter from a Thraustochytriales polyketide synthase system, and fatty acid desaturase promoter
09/04/2003US20030166199 Serine dehydratase homolog
09/04/2003US20030166196 Fusion proteins and polynucleotides encoding gelonin sequences
09/04/2003US20030166191 Promoter-regulatory gene operons which repress transcription; use for regulating gene expression in a cell
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/04/2003US20030166180 Contacting 3-hydroxynitrile with enzyme catalyst having nitrile hydratase, amidase or nitrilase activity; use in copolyesters
09/04/2003US20030166179 Methods and materials for the synthesis of organic products
09/04/2003US20030166175 Process for clavulanic acid production
09/04/2003US20030166174 Fermenting amino acids using lysine resistant methanobacterium for animal feeds, foodstuffs and drug design
09/04/2003US20030166173 Nucleotide sequences coding for the glbO gene
09/04/2003US20030166171 Genes encoding exopolysaccharide production
09/04/2003US20030166166 Deregulation of glutamine PRPP amidotransferase activity
09/04/2003US20030166165 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166157 Genetically engineered plasmid for preparing bovine growth hormone in escherichia
09/04/2003US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/04/2003US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166116 Nucleotide sequences for the control of the expression of DNA sequences in a cell host
09/04/2003US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases
09/04/2003US20030166061 14273 receptor, a novel G-protein coupled receptor
09/04/2003US20030166060 58297, an amino acid transporter and uses therefor
09/04/2003US20030166053 Plasmid which prolongs bacterial viability during fermentation
09/04/2003US20030166048 Epidermal growth factor peptide for diagnosis and treatment cancer; antiproliferative agents
09/04/2003US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant
09/04/2003US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases
09/04/2003US20030166040 Removal of 1,3 propanediol from fermentation broth using in situ chromatography
09/04/2003US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy
09/04/2003US20030166009 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
09/04/2003US20030165968 For hydrolysis of nitrile-containing substrates to carboxylic acids; thermostability
09/04/2003US20030165958 Test and model for Alzheimer's disease
09/04/2003US20030165932 Autoinducer is not an acyl-homoserine lactone and can interact with the Vibrio harveyi LuxQ protein, increasing expression of the operon; drug screening
09/04/2003US20030165926 Method for identifying and isolating genome fragments with coupling disequilibrium
09/04/2003US20030165924 Comprises nucleotide sequences transcribed in cells which accumulate multiple intracellular lipid droplets for diagnosing atherosclerosis
09/04/2003US20030165922 System, method and apparatus for transgenic and targeted mutagenesis screening
09/04/2003US20030165909 Screening cell sample for presence of lung nucleotide sequences (LS170) for diagnosing, classifying, monitoring, prognosing, in situ imaging, preventing or treating lung diseases, tumors or metastases
09/04/2003US20030165907 Human glycine transporter type 2
09/04/2003US20030165889 Identifying and detecting virulence determinant genes of Legionella pneumophila in cells; diagnosing infections
09/04/2003US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP
09/04/2003US20030165872 Comprises nucleotide sequences coding protozoan parasite protein for diagnosis and prevention of infections; veterinary medicine; miticides; parasiticides; dog vaccine
09/04/2003US20030165870 Comprises nucleotide sequences of enteric bacteria for diagnosis and detection of infection in humans and animals; veterinary medicine
09/04/2003US20030165848 Secreted Proteins and Nucleic Acids Encoding Them
09/04/2003US20030165537 Vaccination against host cell-associated herpes viruses
09/04/2003US20030165534 Modified DNA molecule, recombinant containing the same, and uses thereof
09/04/2003US20030165532 Extracts from the fungus Guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus Gignardia sp. and its use in pharmaceutical compositions
09/04/2003US20030165528 Streptococcus pyogenes antigens
09/04/2003US20030165527 Streptococcus vaccine; veterinary medicine
09/04/2003US20030165524 Immunization of dairy cattle with GapC protein against Streptococcus infection
09/04/2003US20030165523 Prevent infections from mites
09/04/2003US20030165520 Attenuated forms of bovine viral diarrhea virus
09/04/2003US20030165511 Protein-virus Complex; culture product; viricides
09/04/2003US20030165507 Postexposure prophylaxis therapy
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165496 Alzheimer's disease
09/04/2003US20030165493 Antithrombin protein and DNA sequences from black fly
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165472 Storage and delivery of micro-organisms
09/04/2003CA2517027A1 Minicell compositions and methods
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
09/04/2003CA2477295A1 Trans-splicing mediated imaging of gene expression
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477243A1 Modified bace
09/04/2003CA2477225A1 Novel compositions and methods for cancer
09/04/2003CA2476887A1 Gasp1:a follistatin domain containing protein
09/04/2003CA2476846A1 Method for detection of leptin receptor ligands
09/04/2003CA2476666A1 Haemophilus adherence and penetration proteins
09/04/2003CA2476654A1 Follistatin domain containing proteins
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2476041A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340814A1 Thermostable xylanases
09/03/2003EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1489